
Duolingo surges as AI-led growth, forecast raise boost investor confidence
The company is maintaining user growth by experimenting with app features, using social engagement strategies and optimizing its subscription offerings to retain users and attract new ones.
Duolingo runs experiments to determine which of its subscriptions are shown to which user and when, with the goal of maximizing long-term platform value rather than pushing any single plan.
Average revenue per user grew 6 per cent in the second quarter, driven largely by users migrating to Duolingo's higher-priced Max tier, which offers features such as AI-powered video calls for practicing conversational skills. It also saw growth in its $12.99-per-month Super plan.
"While we maintain a more cautious stance on near-term user growth, we see several sources of upside still in the model, most notably across monetization efforts (price and improving paid conversion) and margins," Raymond James analysts said in a note.
Duolingo's gross margin declined 100 basis points during the quarter, less than the 300-basis-point fall it had anticipated, due to lower-than-expected AI costs and stronger performance in ads business.
"We did better on gross margin, in part because AI costs that power Max were lower than we expected, the cost of calling AI tools has come down a lot," Chief Financial Officer Matt Skarupa told Reuters.
The company posted adjusted profit per share of 91 cents, surpassing analysts' estimate of 58 cents, prompting them to boost earnings expectations.
It is set to add roughly $4.6 billion to its $15.62 billion market valuation, if premarket levels hold.
Still, as of Wednesday's close, Duolingo shares traded at 85.21 times profit expectations before the results, above internet services companies such as Uber's 26.54 and DoorDash's 79.38.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
13 minutes ago
- Business Times
Chinese flu shot maker soars in Hong Kong trading debut
[HONG KONG] Ab&B Bio-Tech soared as much as 169 per cent in its trading debut in Hong Kong, after retail investors flocked to the Chinese vaccine maker's initial public offering (IPO). The stock climbed to as high as HK$34.64 per share on Monday (Aug 11) morning, more than double its HK$12.90 IPO price, which was set at the low end of the marketed range. The share sale's success builds on the rally of health-care stocks, which have been the best performers on the Hang Seng Composite Index this year. Ab&B, which sells an influenza vaccine, was so sought after among retail investors that they applied for more than US$20 billion worth of margin loans to bid for the stock. That's thousands of times the number of shares available to them. Ab&B is also the last company to go public in Hong Kong under listing rules that allowed retail investors to grab as much as half of all allocated shares in an oversubscribed new listing. Starting this August, mom-and-pop investors will only be able to get up to 35 per cent of such deals. Aside from flu shots, Ab&B is also developing vaccines for rabies, herpes and other respiratory diseases, with plans to commercialise them in China and beyond. Though much smaller in scale, Ab&B follows other health-care companies in starting out with a bang in Hong Kong this year. Cancer drugmakers Duality Biotherapeutics and Nanjing Leads Biolabs saw their stocks more than double on their trading debuts. BLOOMBERG


CNA
13 minutes ago
- CNA
CNA938 Rewind - New US$15,000 visa bond: What to know about travel visa and its significance
Following the US' announcement that bonds of up to US$15,000 for some tourist and business visas could be required under a pilot programme, Hairianto Diman and Susan Ng find out more about travel visas and their significance in today's highly inter-connected world from Scott Moore, Managing Director, Henley and Partners


CNA
2 hours ago
- CNA
Oil prices fall as market eyes US-Russia talks on Ukraine
BEIJING :Oil prices fell in early Asian trading on Monday, extending declines of more than 4 per cent last week on higher U.S. tariffs on its trading partners, an OPEC output hike, and expectations the U.S. and Russia were moving closer to a Ukraine ceasefire pact. Brent crude futures fell 52 cents, or 0.78 per cent, to $66.07 a barrel by 0041 GMT, while U.S. West Texas Intermediate crude futures fell 58 cents to $63.30. Expectations have risen for a potential end to sanctions that have limited the supply of Russian oil to international markets, after U.S. President Donald Trump said on Friday that he would meet with Russian President Vladimir Putin on August 15 in Alaska to negotiate an end to the war in Ukraine. The news came as the U.S. has stepped up pressure on Russia, raising the prospect that penalties on Moscow could also be tightened if a peace deal isn't reached. Trump set a deadline of last Friday for Russia to agree to peace in Ukraine or have its oil buyers face secondary sanctions, and at the same time is pressing India to reduce purchases of Russian oil. On top of U.S.-Russia talks, U.S. inflation data on Tuesday will be another key price driver this week, IG market analyst Tony Sycamore said in a note. "A weaker-than-expected CPI print would boost expectations for earlier and deeper Fed interest rate cuts, which would likely stimulate economic activity and increase crude oil demand." "Conversely a hotter print would spark stagflation fears and push back expectations of Fed rate cuts." Trump's higher tariffs on imports from dozens of countries, which took effect on Thursday, are expected to weigh on economic activity as they force rerouting of supply chains and higher inflation.